The “Pfizer” vaccine precedes everyone to fulfill the “Trump promise”

The company general manager said "Moderna"Stephan Bancel at a newspaper conference "Financial Times" it’s a "We will have enough safety data on November 25, to be able to submit an emergency request to the Food and Drug Administration, provided the safety data is good, that is, it is considered The vaccine Safe".

وتجري "Moderna" Add to my company "Pfizer" And"Johnson & Johnson" The third phase of clinical trials on experimental vaccines for the virus, during which tens of thousands of volunteers are injected with the vaccine, and a similar number for them with a placebo vaccine, in order to verify the effectiveness and safety of the vaccine.

There is a fourth vaccine in United State This reached the third stage, however Clinical trials It is temporarily suspended, a vaccine developed by a company "AstraZeneca" In cooperation with the University of Oxford.

And through the US President Donald Trump Several times he hoped to find a vaccine before the November 3 elections, raising concerns among public health experts from the practice "Political pressure" On the regulatory process to adopt VaccinesAccording to what was quoted "France Brush".

And alone is a company "Pfizer" It expects to achieve results by the end of October, days before the polling date, allowing the company to immediately file a license application with the Food and Drug Administration.

The testing protocol provides for a relatively quick analysis of data, but scientists and statisticians in the field of biology and experts in clinical tests have warned of the risks of granting accelerated approval, and preferred to test the vaccine for a few additional months, to ensure its effectiveness and possible side effects.

“>

“We will have enough safety data on November 25, to be able to submit an emergency request to the Food and Drug Administration, provided that the safety data are good, that is, it is considered,” Moderna’s general manager, Stephan Bancel, said during a conference organized by the Financial Times. The vaccine Safe. “

Moderna, in addition to Pfizer and Johnson & Johnson, is conducting the third phase of clinical trials on experimental vaccines for the virus, during which tens of thousands of volunteers are injected with the vaccine, and a similar number to them with a placebo vaccine, in order to verify the effectiveness and safety of the vaccine.

There is a fourth vaccine in United State This reached the third stage, however Clinical trials It was temporarily suspended, and it is a vaccine developed by AstraZeneca in cooperation with the University of Oxford.

And through the US President Donald Trump Several times, he hoped to find a vaccine before the November 3 elections, which raised fears among public health experts that “political pressure” would be put on the regulatory process to adopt VaccinesAccording to “Agence France Presse”.

Only Pfizer expects to achieve results by the end of October, days before the polling date, allowing the company to immediately file a license application from the Food and Drug Administration.

The testing protocol provides for a relatively quick analysis of data, but scientists and statisticians in the field of biology and experts in clinical tests have warned of the risks of granting accelerated approval, and preferred to test the vaccine for a few additional months, to ensure its effectiveness and possible side effects.

.

Comments

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Trending